Discovery of thiazolidinedione-based pancreatic lipase inhibitors as anti-obesity agents: synthesis, in silico studies and pharmacological investigations

References

• Aloulou, A., & Carrière, F. (2008). Gastric lipase: An extremophilic interfacial enzyme with medical applications. Cellular and Molecular Life Sciences: CMLS, 65(6), 851–854. https://doi.org/10.1007/s00018-008-7546-z
   PubMed Web of Science ®Google Scholar
• Aneja, D. K., Lohan, P., Arora, S., Sharma, C., Aneja, K. R., & Prakash, O. (2011). Synthesis of new pyrazolyl-2,4-thiazolidinediones as antibacterial and antifungal agents. Organic and Medicinal Chemistry Letters, 1(1), 15. https://doi.org/10.1186/2191-2858-1-15
   PubMedGoogle Scholar
• Auti, P. S., Nandi, A., Kumari, V., & Paul, A. T. (2022). Design, synthesis, biological evaluation and molecular modelling studies of oxoacetamide warhead containing indole-quinazolinone based novel hybrid analogues as potential pancreatic lipase inhibitors. New Journal of Chemistry, 46(24), 11648–11661. https://doi.org/10.1039/D2NJ01210C
   Web of Science ®Google Scholar
• Baidya, S. K., Banerjee, S., Ghosh, B., Jha, T., & Adhikari, N. (2023). Assessing structural insights into in-house arylsulfonyl L-(+) glutamine MMP-2 inhibitors as promising anticancer agents through structure-based computational modelling approaches. SAR and QSAR in Environmental Research, 34(10), 805–830. https://doi.org/10.1080/1062936X.2023.2261842
   PubMed Web of Science ®Google Scholar
• Banerjee, S., Baidya, S. K., Ghosh, B., Nandi, S., Mandal, M., Jha, T., & Adhikari, N. (2023). Quantitative structural assessments of potential meprin b inhibitors by non-linear QSAR approaches and validation by binding mode of interaction analysis. New Journal of Chemistry, 47(15), 7051–7069. https://doi.org/10.1039/D2NJ04753E
   Web of Science ®Google Scholar
• Batterham, R. L., Le Roux, C. W., Cohen, M. A., Park, A. J., Ellis, S. M., Patterson, M., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003). Pancreatic polypeptide reduces appetite and food intake in humans. The Journal of Clinical Endocrinology and Metabolism, 88(8), 3989–3992. https://doi.org/10.1210/jc.2003-030630
   PubMed Web of Science ®Google Scholar
• Birari, R. B., Gupta, S., Mohan, C. G., & Bhutani, K. K. (2011). Anti-obesity and lipid lowering effects of Glycyrrhiza chalcones: Experimental and computational studies. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 18(8–9), 795–801. https://doi.org/10.1016/j.phymed.2011.01.002
   PubMed Web of Science ®Google Scholar
• Bjerregaard, L. G., Jensen, B. W., Ängquist, L., Osler, M., Sørensen, T. I., & Baker, J. L. (2018). Change in overweight from childhood to early adulthood and risk of type 2 diabetes. New England Journal of Medicine, 378(14), 1302–1312. https://doi.org/10.1056/NEJMoa1713231
   PubMed Web of Science ®Google Scholar
• Burlingham, B. T., & Widlanski, T. S. (2003). An intuitive look at the relationship of Ki and IC50: A more general use for the Dixon plot. Journal of Chemical Education, 80(2), 214. https://doi.org/10.1021/ed080p214
   Web of Science ®Google Scholar
• Cardullo, N., Muccilli, V., Pulvirenti, L., & Tringali, C. (2021). Natural isoflavones and semisynthetic derivatives as pancreatic lipase inhibitors. Journal of Natural Products, 84(3), 654–665. https://doi.org/10.1021/acs.jnatprod.0c01387
   PubMed Web of Science ®Google Scholar
• Chauhan, D., George, G., Sridhar, S., Bhatia, R., Paul, A. T., & Monga, V. (2019). Design, synthesis, biological evaluation, and molecular modeling studies of rhodanine derivatives as pancreatic lipase inhibitors. Archiv Der Pharmazie, 352(10), e1900029. https://doi.org/10.1002/ardp.201900029
   PubMed Web of Science ®Google Scholar
• De Caro, A., Figarella, C., Amic, J., Michel, R., & Guy, O. (1977). Human pancreatic lipase: A glycoprotein. Biochimica et Biophysica Acta, 490(2), 411–419. https://doi.org/10.1016/0005-2795(77)90016-2
   PubMedGoogle Scholar
• Doll, S., Paccaud, F., Bovet, P., Burnier, M., & Wietlisbach, V. (2002). Body mass index, abdominal adiposity and blood pressure: Consistency of their association across developing and developed countries. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity, 26(1), 48–57. https://doi.org/10.1038/sj.ijo.0801854
   PubMed Web of Science ®Google Scholar
• Downie, I. M., Earle, J. M., Heaney, H., & Shuhaibar, K. (1993). Vilsmeier formylation and glyoxylation reactions of nucleophilic aromatic compounds using pyrophosphoryl chloride. Tetrahedron, 19(4):4015–434.
   Google Scholar
• Eydoux, C., Spinelli, S., Davis, T. L., Walker, J. R., Seitova, A., Dhe-Paganon, S., De Caro, A., Cambillau, C., & Carrière, F. (2008). Structure of human pancreatic lipase-related protein 2 with the lid in an open conformation. Biochemistry, 47(36), 9553–9564. https://doi.org/10.1021/bi8005576
   PubMed Web of Science ®Google Scholar
• Filippatos, T. D., Derdemezis, C. S., Gazi, I. F., Nakou, E. S., Mikhailidis, D. P., & Elisaf, M. S. (2008). Orlistat-associated adverse effects and drug interactions. Drug Safety, 31(1), 53–65. https://doi.org/10.2165/00002018-200831010-00005
   PubMed Web of Science ®Google Scholar
• George, G., Auti, P. S., & Paul, A. T. (2021). Design, synthesis and biological evaluation of N‐substituted indole‐thiazolidinedione analogues as potential pancreatic lipase inhibitors. Chemical Biology & Drug Design, 98(1), 49–59. https://doi.org/10.1111/cbdd.13846
   PubMed Web of Science ®Google Scholar
• George, G., Auti, P. S., & Paul, A. T. (2021). Design, synthesis, in silico molecular modelling studies and biological evaluation of novel indole-thiazolidinedione hybrid analogues as potential pancreatic lipase inhibitors. New Journal of Chemistry, 45(3), 1381–1394. https://doi.org/10.1039/D0NJ05649A
   Web of Science ®Google Scholar
• George, G., Auti, P. S., Sengupta, P., Yadav, N., & Paul, A. T. (2023). Synthesis, molecular modelling and pharmacological evaluation of novel indole-thiazolidinedione based hybrid analogues as potential pancreatic lipase inhibitors. Journal of Biomolecular Structure & Dynamics, 1–20. https://doi.org/10.1080/07391102.2023.2293255
   Web of Science ®Google Scholar
• George, G., Yadav, N., Auti, P. S., & Paul, A. T. (2023). Molecular modelling, synthesis and in vitro evaluation of quinazolinone hybrid analogues as potential pancreatic lipase inhibitors. Journal of Biomolecular Structure & Dynamics, 41(19), 9583–9601. https://doi.org/10.1080/07391102.2022.2144456
   PubMed Web of Science ®Google Scholar
• Grant, B. J., Rodrigues, A. P., ElSawy, K. M., McCammon, J. A., & Caves, L. S. (2006). (2006). Bio3d: An R package for the comparative analysis of protein structures. Bioinformatics (Oxford, England), 22(21), 2695–2696. https://doi.org/10.1093/bioinformatics/btl461
   PubMed Web of Science ®Google Scholar
• Hadváry, P., Sidler, W., Meister, W., Vetter, W., & Wolfer, H. (1991). The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase. Journal of Biological Chemistry, 266(4), 2021–2027. https://doi.org/10.1016/S0021-9258(18)52203-1
   PubMed Web of Science ®Google Scholar
• Heck, A. M., Yanovski, J. A., & Calis, K. A. (2000). Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy, 20(3), 270–279. https://doi.org/10.1592/phco.20.4.270.34882
   PubMed Web of Science ®Google Scholar
• Kagami, L. P., das Neves, G. M., Timmers, L. F. S. M., Caceres, R. A., & Eifler-Lima, V. L. (2020). Geo-measures: A PyMOL plugin for protein structure ensembles analysis. Computational Biology and Chemistry, 87, 107322. https://doi.org/10.1016/j.compbiolchem.2020.107322
   PubMed Web of Science ®Google Scholar
• Kang, J. G., & Park, C.-Y. (2012). Anti-obesity drugs: A review about their effects and safety. Diabetes & Metabolism Journal, 36(1), 13–25. https://doi.org/10.4093/dmj.2012.36.1.13
   PubMedGoogle Scholar
• Kaur, A., Behl, T., Makkar, R., & Goyal, A. (2019). Effect of ethanolic extract of Cuscuta reflexa on high fat diet-induced obesity in Wistar rats. Obesity Medicine, 14, 100082. https://doi.org/10.1016/j.obmed.2019.02.001
   Google Scholar
• Kotsovolou, S., Chiou, A., Verger, R., & Kokotos, G. (2001). Bis-2-oxo amide triacylglycerol analogues: A novel class of potent human gastric lipase inhibitors. The Journal of Organic Chemistry, 66(3), 962–967. https://doi.org/10.1021/jo005705y
   PubMed Web of Science ®Google Scholar
• Kumar, A., & Chauhan, S. (2021). Pancreatic lipase inhibitors: The road voyaged and successes. Life Sciences, 271, 119115.
   PubMed Web of Science ®Google Scholar
• Liu, T.-T., Liu, X.-T., Chen, Q.-X., & Shi, Y. (2020). Lipase inhibitors for obesity: A review. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 128, 110314. https://doi.org/10.1016/j.biopha.2020.110314
   PubMed Web of Science ®Google Scholar
• Liu K, Ding Y, & Kang C. (2020). Synthesis and antiproliferative activity of new N-acylhydrazone derivatives containing Benzothiazole and indole based moiety.Pharmaceutical Chemistry Journal, 54, 345–352. https://doi.org/10.1007/s11094-020-02215-w
   Web of Science ®Google Scholar
• Lowe, M. E. (1994). Pancreatic triglyceride lipase and colipase: Insights into dietary fat digestion. Gastroenterology, 107(5), 1524–1536. https://doi.org/10.1016/0016-5085(94)90559-2
   PubMed Web of Science ®Google Scholar
• Lowe, M. E. (1997). Molecular mechanisms of rat and human pancreatic triglyceride lipases. The Journal of Nutrition, 127(4), 549–557. https://doi.org/10.1093/jn/127.4.549
   PubMed Web of Science ®Google Scholar
• Ma, J., Bao, G., Wang, L., Li, W., Xu, B., Du, B., Lv, J., Zhai, X., & Gong, P. (2015). Design, synthesis, biological evaluation and preliminary mechanism study of novel benzothiazole derivatives bearing indole-based moiety as potent antitumor agents. European Journal of Medicinal Chemistry, 96, 173–186. https://doi.org/10.1016/j.ejmech.2015.04.018
   PubMed Web of Science ®Google Scholar
• Martins, T., Castro-Ribeiro, C., Lemos, S., Ferreira, T., Nascimento-Gonçalves, E., Rosa, E., Oliveira, P. A., & Antunes, L. M. (2022). Murine models of obesity. Obesities, 2(2), 127–147. https://doi.org/10.3390/obesities2020012
   Google Scholar
• Nakai, M., Fukui, Y., Asami, S., Toyoda-Ono, Y., Iwashita, T., Shibata, H., Mitsunaga, T., Hashimoto, F., & Kiso, Y. (2005). Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. Journal of Agricultural and Food Chemistry, 53(11), 4593–4598. https://doi.org/10.1021/jf047814+
   PubMed Web of Science ®Google Scholar
• Nomura, D. K., & Casida, J. E. (2016). Lipases and their inhibitors in health and disease. Chemico-Biological Interactions, 259, 211–222. https://doi.org/10.1016/j.cbi.2016.04.004
   PubMed Web of Science ®Google Scholar
• Novelli, E. L., Diniz, Y. S., Galhardi, C. M., Ebaid, G. M., Rodrigues, H. G., Mani, F., Fernandes, A. A., Cicogna, A. C., & Novelli Filho, J. L. (2007). Anthropometrical parameters and markers of obesity in rats. Laboratory Animals, 41(1), 111–119. https://doi.org/10.1258/002367707779399518
   PubMed Web of Science ®Google Scholar
• Oldham, S. (2011). Obesity and nutrient sensing TOR pathway in flies and vertebrates: Functional conservation of genetic mechanisms. Trends in Endocrinology and Metabolism: TEM, 22(2), 45–52. https://doi.org/10.1016/j.tem.2010.11.002
   PubMed Web of Science ®Google Scholar
• Sandeep, S., Priyadarshini, V., Pradhan, D., Munikumar, M., & Umamaheswari, A. (2012). Docking and molecular dynamics simulations studies of human protein kinase catalytic subunit alpha with antagonist. Journal of Clinical and Scientific Research, 1(1), 15–23. https://doi.org/10.4103/2277-5706.241211
   Google Scholar
• Schwartz, S. L. (2006). Diabetes and dyslipidaemia. Diabetes, Obesity & Metabolism, 8(4), 355–364. https://doi.org/10.1111/j.1463-1326.2005.00516.x
   PubMed Web of Science ®Google Scholar
• Shetty, S. C., & Bhagat, V. C. (2008). Synthesis and pharmacological activities of 3-(4-substituted phenyl)-1-phenyl-1H-pyrazole-4-carboxaldehyde and its aldimines derivatives. Asian Jounal of Chemistry, 20, 5037–5045.
   Web of Science ®Google Scholar
• SN C, S., Sengupta, P., Palawat, S., PS, D., George, G., & Paul, A. T. (2022). Synthesis, molecular modelling, in vitro and in vivo evaluation of conophylline inspired novel benzyloxy substituted indole glyoxylamides as potent pancreatic lipase inhibitors. Journal of Biomolecular Structure & Dynamics, 40(19), 9530–9542.
   PubMed Web of Science ®Google Scholar
• Sridhar, S., Bhurta, D., Kantiwal, D., George, G., Monga, V., & Paul, A. T. (2017). Design, synthesis, biological evaluation and molecular modelling studies of novel diaryl substituted pyrazolyl thiazolidinediones as potent pancreatic lipase inhibitors. Bioorganic & Medicinal Chemistry Letters, 27(16), 3749–3754. https://doi.org/10.1016/j.bmcl.2017.06.069
   PubMed Web of Science ®Google Scholar
• Sridhar, S., Ginson, G., Reddy, P. V., Tantak, M. P., Kumar, D., & Paul, A. T. (2017). Synthesis, evaluation and molecular modelling studies of 2-(carbazol-3-yl)-2-oxoacetamide analogues as a new class of potential pancreatic lipase inhibitors. Bioorganic & Medicinal Chemistry, 25(2), 609–620. https://doi.org/10.1016/j.bmc.2016.11.031
   PubMed Web of Science ®Google Scholar
• Storlien, L. H., Jenkins, A. B., Chisholm, D. J., Pascoe, W. S., Khouri, S., & Kraegen, E. W. (1991). Influence of dietary fat composition on development of insulin resistance in rats: Relationship to muscle triglyceride and ω-3 fatty acids in muscle phospholipid. Diabetes, 40(2), 280–289. https://doi.org/10.2337/diab.40.2.280
   PubMed Web of Science ®Google Scholar
• Verma, R., Bhatia, R., Singh, G., Kumar, B., Mehan, S., & Monga, V. (2020). Design, synthesis and neuropharmacological evaluation of new 2,4-disubstituted-1,5-benzodiazepines as CNS active agents. Bioorganic Chemistry, 101, 104010. https://doi.org/10.1016/j.bioorg.2020.104010
   PubMed Web of Science ®Google Scholar
• Vo, C.-V T., Nguyen, L. C., Le, T. T. A., Dang, T. N., Dao, M. Q., Nguyen, T. H., Vo, M. H., Van Truong, D., Nguyen, Q.-T., Nguyen, P. T. V., & Tran, T.-D. (2022). Natural mimetic 4-benzyloxychalcones as potent pancreatic lipase inhibitors: Virtual screening, synthesis and biological evaluation. Phytochemistry Letters, 51, 28–33. https://doi.org/10.1016/j.phytol.2022.06.011
   Web of Science ®Google Scholar
• WHO European Regional Obesity. (2022, May 3). World Health Organization Regional Office for Europe Website. https://apps. who.int/iris/bitstream/handle/10665/353747/9789289057738-eng.pdf
   Google Scholar
• Winkler, F., d‘Arcy, A., & Hunziker, W. (1990). Structure of human pancreatic lipase. Nature, 343(6260), 771–774. https://doi.org/10.1038/343771a0
   PubMed Web of Science ®Google Scholar
• Woods, S. C., Seeley, R. J., Rushing, P. A., D'Alessio, D., & Tso, P. A. (2003). A controlled high-fat diet induces an obese syndrome in rats. The Journal of Nutrition, 133(4), 1081–1087. https://doi.org/10.1093/jn/133.4.1081
   PubMed Web of Science ®Google Scholar
• World Obesity Atlas. (2022). World Obesity Federation, 2022.
   Google Scholar
• Yadav, N., & Paul, A. T. (2023). Synthesis of amide warhead containing coumarin derivatives as potential pancreatic lipase inhibitors: In silico and in vitro evaluation for obesity treatment. Medicinal Chemistry Research, 32(10), 2219–2233. https://doi.org/10.1007/s00044-023-03124-9
   Web of Science ®Google Scholar
• Yogia, P., Ashida, M., Hussainb, N., Khanamb, R., & Joshi, K. S. (2015). A. Synthesis of Pyrazoles via Vilsmeier Haack reaction and their pyrazolone, thiazolidinedione derivatives: A comparative study of conventional and microwave routes. Iranian Journal of Organic Chemistry, 7(2), 1515–1522.
   Google Scholar